Milestone Pharmaceuticals (MIST) Assets (2018 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Assets came in at $193.7 million in Q1 2026, up 213.05% YoY from $61.9 million in Q1 2025, and up 70.6% on a QoQ basis from $113.6 million in Q4 2025.
Milestone Pharmaceuticals (MIST) Assets (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 9 years of Assets data on file, last reported at $193.7 million in Q1 2026.
- Quarterly Assets rose 213.05% year-over-year to $193.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.7 million (up 213.05% YoY) and the FY2025 annual result came in at $113.6 million, up 50.41% from the prior year.
- Assets advanced to $193.7 million in Q1 2026, from $113.6 million in the prior quarter.
- In the past five years, Assets ranged from a high of $193.7 million in Q1 2026 to a low of $47.4 million in Q2 2025.
- A 5-year average of $92.7 million and a median of $87.8 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2025 — Assets tumbled 46.86% — and 2026, when it surged 213.05%.
- Tracing MIST's Assets over 5 years: stood at $74.5 million in 2022, then advanced by 1.0% to $75.2 million in 2023, then gained by 0.36% to $75.5 million in 2024, then surged by 50.41% to $113.6 million in 2025, then jumped by 70.6% to $193.7 million in 2026.
- The last three Assets figures came in at $193.7 million (Q1 2026), $113.6 million (Q4 2025), and $87.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - | 181.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 181.63 Mn |
| Mar 31, 2026 | 193.73 Mn |
| Dec 31, 2025 | 113.56 Mn |
| Sep 30, 2025 | 87.75 Mn |
| Jun 30, 2025 | 47.42 Mn |
| Mar 31, 2025 | 61.89 Mn |
| Dec 31, 2024 | 75.50 Mn |
| Sep 30, 2024 | 82.71 Mn |
| Jun 30, 2024 | 89.23 Mn |
| Mar 31, 2024 | 96.00 Mn |
| Dec 31, 2023 | 75.23 Mn |
| Sep 30, 2023 | 87.12 Mn |
| Jun 30, 2023 | 97.02 Mn |
| Mar 31, 2023 | 111.08 Mn |
| Dec 31, 2022 | 74.48 Mn |
| Sep 30, 2022 | 85.77 Mn |
| Jun 30, 2022 | 91.30 Mn |
| Mar 31, 2022 | 105.80 Mn |
| Dec 31, 2021 | 119.85 Mn |
| Sep 30, 2021 | 133.78 Mn |